Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Dec 10:219:396-405.
doi: 10.1016/j.jconrel.2015.07.030. Epub 2015 Aug 1.

Using exosomes, naturally-equipped nanocarriers, for drug delivery

Elena V Batrakova  1 , Myung Soo Kim  2
Affiliations
Review

Using exosomes, naturally-equipped nanocarriers, for drug delivery

Elena V Batrakova et al. J Control Release. .

Abstract

Exosomes offer distinct advantages that uniquely position them as highly effective drug carriers. Comprised of cellular membranes with multiple adhesive proteins on their surface, exosomes are known to specialize in cell-cell communications and provide an exclusive approach for the delivery of various therapeutic agents to target cells. In addition, exosomes can be amended through their parental cells to express a targeting moiety on their surface, or supplemented with desired biological activity. Development and validation of exosome-based drug delivery systems are the focus of this review. Different techniques of exosome isolation, characterization, drug loading, and applications in experimental disease models and clinic are discussed. Exosome-based drug formulations may be applied to a wide variety of disorders such as cancer, various infectious, cardiovascular, and neurodegenerative disorders. Overall, exosomes combine benefits of both synthetic nanocarriers and cell-mediated drug delivery systems while avoiding their limitations.

Keywords: Drug delivery; Exosomes; Extracellular vesicles; Nanotechnology.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
A profound accumulation of exosomes (A, red) compared to polymer-based nanoparticles (B, red) in target PC12 neuronal cells stained for actin microfilaments (green) and nuclei (blue). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Fig. 2
Fig. 2
Schematic representation of different types of extracellular vesicles.
Fig. 3
Fig. 3
Different approached for drug loading into exosomes.
Fig. 4
Fig. 4
The flow of the production and delivery of exosomal drug formulations to the patient.
See this image and copyright information in PMC

References

    1. Peng Q, Zhang S, Yang Q, Zhang T, Wei XQ, Jiang L, Zhang CL, Chen QM, Zhang ZR, Lin YF. Preformed albumin corona, a protective coating for nanoparticles based drug delivery system. Biomaterials. 2013;43:8521–8530. - PubMed
    1. Beckman JS, Minor RL, Jr., White CW, Repine JE, Rosen GM, Freeman BA. Superoxide dismutase and catalase conjugated to polyethylene glycol increases endothelial enzyme activity and oxidant resistance. J. Biol. Chem. 1988;263:6884–6892. - PubMed
    1. Yoshida K, Burton GF, McKinney JS, Young H, Ellis EF. Brain and tissue distribution of polyethylene glycol-conjugated superoxide dismutase in rats. Stroke. 1992;23:865–869. - PubMed
    1. Veronese FM, Caliceti P, Schiavon O, Sergi M. Polyethylene glycol-superoxide dismutase, a conjugate in search of exploitation. Adv. Drug Deliv. Rev. 2002;54:587–606. - PubMed
    1. Dams ET, Laverman P, Oyen WJ, Storm G, Scherphof GL, van Der Meer JW, Corstens FH, Boerman OC. Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. J. Pharmacol. Exp. Ther. 2000;292:1071–1079. - PubMed

Publication types